UBS analyst Peter Grom raised the firm’s price target on Colgate-Palmolive (CL) to $93 from $90 and keeps a Buy rating on the shares. The operating environment and market backdrop for Consumer Staples remains challenging, but fundamentals could improve in 2026, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- AMD upgraded, Arm downgraded: Wall Street’s top analyst calls
- Colgate-Palmolive upgraded to Equal Weight from Underweight at Wells Fargo
- The Week That Was, The Week Ahead: Macro and Markets, Jan. 11
- Texas AG announces agreement with P&G on fluoride in children’s toothpaste
- Colgate-Palmolive price target lowered to $86 from $90 at TD Cowen